Thymosin Beta-4 Research Guide

Full name: Thymosin Beta-4 (Full Length)

A 43-amino acid peptide that is the primary G-actin sequestering molecule in mammalian cells. Plays a critical role in tissue repair, regeneration, and protection after injury.

How Thymosin Beta-4 Works

Sequesters G-actin to regulate cytoskeleton dynamics, promotes stem cell differentiation, and activates anti-inflammatory and anti-apoptotic pathways.

Dosing Protocol

• Typical dose: 1-5 mg
• Frequency: 2-3x per week
• Duration: 4-12 weeks
• Route: Subcutaneous injection

Reported Benefits

• Comprehensive tissue repair
• Cardiac regeneration
• Neurological recovery
• Corneal healing
• Anti-fibrotic effects

Potential Side Effects

• Injection site swelling
• Temporary fatigue
• Mild headache

Research Citations

1. Thymosin beta-4 in cardiac repair (2020) - Promoted cardiomyocyte survival and neovascularization post-ischemic injury.
2. Corneal wound healing with Tβ4 (2018) - Accelerated corneal re-epithelialization and reduced scarring in clinical evaluation.

Related Healing & Recovery Compounds

• BPC-157 - Full Profile
• TB-500 - Full Profile
• Pentosan Polysulfate - Full Profile
• KPV - Full Profile
• LL-37 - Full Profile
• BPC-157 (Oral) - Full Profile

View full Thymosin Beta-4 profile with 3D molecule viewer →